A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Felodipine Extended-Release Tablets (Felodipine)

Felodipine Extended-Release Tablets relaxes blood vessels to lower blood pressure and treat angina.

First FDA approval2019-08-01
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Felodipine Extended-Release Tablets used for?

Felodipine Extended-Release Tablets relaxes blood vessels to lower blood pressure and treat angina.

Is there a generic for Felodipine Extended-Release Tablets?

No. Felodipine Extended-Release Tablets is brand-only with no generic equivalents currently in market.

How much does my plan pay for Felodipine Extended-Release Tablets?

NADAC pricing data not currently available for this drug.

Is Felodipine Extended-Release Tablets on the FDA shortage list?

No. Felodipine Extended-Release Tablets is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Dihydropyridine Calcium Channel Blocker6 alternatives in D1
01
Amlodipine
Brand: Katerzia
$0.011Lowest NADAC
19Generic mfrs
$515.5MCY24 Part D spend
Compare →
02
Amlodipine and Atorvastatin
Brand: Caduet
$1.01Lowest NADAC
5Generic mfrs
CY24 Part D spend
Compare →
03
Amlodipine and Benazepril
Brand: Lotrel
$0.094Lowest NADAC
5Generic mfrs
CY24 Part D spend
Compare →
04
Amlodipine and Olmesartan Medoxomil
Brand: Azor
$0.240Lowest NADAC
9Generic mfrs
CY24 Part D spend
Compare →
05
Clevidipine
Brand: Cleviprex
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
06
Clevipidine
Brand: Cleviprex
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.